Task Force criteria for HD IL-2 therapy
| Criterion | Rankinga |
|---|---|
| Physiologic features | |
| Clear cell histology - no papillary or granular features | 1.21 |
| Adequate heart and lung function | 3.57 |
| Performance Status | 3.71 |
| Age (physiology ≤ 70 years) | 4.64 |
| Prior nephrectomy | 4.93 |
| Lack of CNS metastases (or treated) | 5.42 |
| Low priority | |
| No prior TKI use | 7.27 |
| MSKCC risk group | 7.36 |
| VLack of bone metastases | 7.40 |
| Lack of liver metastases | 8.56 |
| Lack of sarcomatoid histology | 9.00 |
| CA IX status | 10.78 |
| Other | 11.00 |
aEach criterion was ranked from highest priority to lowest priority with 1 indicating the highest priority